Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Scott E, Woodman"'
Autor:
Mahsa Madani, Drew Goldstein, Roxana Stefanescu, Scott E. Woodman, Cristhiam M. Rojas‐Hernandez
Publikováno v:
Cancer Medicine, Vol 11, Iss 20, Pp 3771-3785 (2022)
Abstract There is a lack of data focused on the specific coagulopathic derangements in COVID‐19 versus non‐COVID‐19 acutely ill cancer patients. Our objective was to characterize features of coagulopathy in cancer patients with active COVID‐1
Externí odkaz:
https://doaj.org/article/66b4dd739d48435a9e18a1cb020d54c8
Autor:
Miles C. Andrews, Junna Oba, Chang-Jiun Wu, Haifeng Zhu, Tatiana Karpinets, Caitlin A. Creasy, Marie-Andrée Forget, Xiaoxing Yu, Xingzhi Song, Xizeng Mao, A. Gordon Robertson, Gabriele Romano, Peng Li, Elizabeth M. Burton, Yiling Lu, Robert Szczepaniak Sloane, Khalida M. Wani, Kunal Rai, Alexander J. Lazar, Lauren E. Haydu, Matias A. Bustos, Jianjun Shen, Yueping Chen, Margaret B. Morgan, Jennifer A. Wargo, Lawrence N. Kwong, Cara L. Haymaker, Elizabeth A. Grimm, Patrick Hwu, Dave S. B. Hoon, Jianhua Zhang, Jeffrey E. Gershenwald, Michael A. Davies, P. Andrew Futreal, Chantale Bernatchez, Scott E. Woodman
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
The regulation of the distinct intrinsic phenotypic states in melanoma remain poorly characterised. Here, multi-omics analysis for a panel of 68 early passage melanoma cell lines reveals that cancer cell intrinsic transcriptomic programs are associat
Externí odkaz:
https://doaj.org/article/96b59787498043a5a256fe86f8315695
Autor:
Bora Lim, Angela Alexander, Jie S. Willey, Huiming Sun, Suyu Liu, Anisha B. Patel, Edwin Roger Parra, Cara Haymaker, Luisa Solis Soto, Alejandra Serrano, Baohua Sun, Cibelle Freitas Pinto Lima, Auriole Tamegnon, Renganayaki K. Pandurengan, Dzifa Douse, Jessica Lan, Luthra Raja, Randy Chu, Mark Knafl, Scott E. Woodman, Haifeng Zhu, Katja Shulze, Katherine Fedenko, Walter Darbonne, Naoto T. Ueno, Vicente Valero
Publikováno v:
Cancer Research. 83:P4-08
Background: Inflammatory breast cancer (IBC) is a rare but aggressive tumor type accounting for up to 10% of breast cancer deaths. One-third of IBCs express high PD-L1 that can be targeted by atezolizumab (Az). MEK inhibitor cobimetinib (Co) not only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::876b128ec6bfb1dd5eca9ba06683d748
https://doi.org/10.1158/1538-7445.sabcs22-p4-08-19
https://doi.org/10.1158/1538-7445.sabcs22-p4-08-19
Autor:
Dereddi Raja Reddy, John A. Cuenca, Joshua Botdorf, Mayoora Muthu, Ankit Hanmandlu, Robert Wegner, John Crommett, Cristina Gutierrez, Nisha Rathi, Bilja Sajith, Mark Knafl, Hussein A. Abbas, Scott E. Woodman, Joseph L. Nates, Ashley Aaroe, Thomas A. Aloia, Lee Andrews, Kiran K. Badami, Janna A. Baganz, Pratibha Bajwa, Lori R. Baker, Gregory R. Barbosa, Hannah C. Beird, Matt Bourgeois, Kristy Brock, Elizabeth M. Burton, Juan Cata, Caroline Chung, Michael Cutherell, Pierre B. Cyr, Bouthaina Dabaja, Hiba Dagher, Kevin M. Daniels, Mary Domask, Giulio Draetta, Sarah Fisher, Katy Elizabeth French, Andrew Futreal, Maria Gaeta, Christopher Gibbons, Myrna Godoy, Drew Goldstein, Jillian Gunther, Cristhiam Hernandez, Kate Hutcheson, David Jaffray, Jeff Jin, Teny Matthew John, Trey Kell, Anai Kothari, Rayson C. Kwan, J. Jack Lee, Yue Liao, Jennifer Litton, Alex Liu, Kevin W. McEnery, Mary McGuire, Tego Musunuru, Craig S. Owen, Priyadharshini Padmakumar, Melody Page, Nicholas Palaskas, Jay J. Patel, Sabitha Prabhakaran, Vinod Ravi, Ludivine Russell, Paul A. Scheet, Stephanie Schmidt, Kenna R. Shaw, Sanjay Shete, Daniel P. Shoenthal, Lessley J. Stoltenberg, Ishwaria Subbiah, Chuck Suitor, Hussein Tawbi, Phillip Thompson, Anastasia Turin, Samir Unni, Benju Vicknamparampil, Max C. Weber, John Weinstein, Zoe Williams, Mark C. Wozny, Carol Wu, Jia Wu, James C. Yao, Chingyi Young, Emily Yu, Steven Zatorski
Publikováno v:
Mayo Clinic Proceedings. 98:451-457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0e4285ed56e25e2fcce40cf942510c3
https://doi.org/10.1016/j.mayocp.2022.12.008
https://doi.org/10.1016/j.mayocp.2022.12.008
Autor:
Michael G. White, Robert Szczepaniak Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews, Ningping Feng, Sarah Johnson, Caleb A. Class, Christopher Bristow, Khalida Wani, Courtney Hudgens, Luigi Nezi, Teresa Manzo, Mariana Pettaccia De Macedo, Jianhua Hu, Richard Davis, Hong Jiang, Peter Prieto, Elizabeth Burton, Patrick Hwu, Hussein Tawbi, Jeffrey Gershenwald, Alexander J. Lazar, Michael T. Tetzlaff, Willem Overwijk, Scott E Woodman, Zachary A. Cooper, Joseph R. Marszalek, Michael A. Davies, Timothy P. Heffernan, Jennifer A. Wargo
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Targeted and immunotherapy regimens have revolutionized the treatment of advanced melanoma patients. Despite this, only a subset of patients respond durably. Recently, combination strategies of BRAF/MEK inhibitors with immune checkpoint inhibitor mon
Externí odkaz:
https://doaj.org/article/e6152b9f5495402183474ea2dacf7022
Autor:
Michael J. Carr, Justin M. Ko, Susan M. Swetter, Scott E. Woodman, Vernon K. Sondak, Kim A. Margolin, Jonathan S. Zager
Publikováno v:
Holland‐Frei Cancer Medicine. :1-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0be83e937d168a1c68a9f717280aa592
https://doi.org/10.1002/9781119000822.hfcm110.pub2
https://doi.org/10.1002/9781119000822.hfcm110.pub2
Autor:
Alexandre Reuben, Christine N. Spencer, Peter A. Prieto, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, John P. Miller, Xizeng Mao, Mariana Petaccia De Macedo, Jiong Chen, Xingzhi Song, Hong Jiang, Pei-Ling Chen, Hannah C. Beird, Haven R. Garber, Whijae Roh, Khalida Wani, Eveline Chen, Cara Haymaker, Marie-Andrée Forget, Latasha D. Little, Curtis Gumbs, Rebecca L. Thornton, Courtney W. Hudgens, Wei-Shen Chen, Jacob Austin-Breneman, Robert Szczepaniak Sloane, Luigi Nezi, Alexandria P. Cogdill, Chantale Bernatchez, Jason Roszik, Patrick Hwu, Scott E. Woodman, Lynda Chin, Hussein Tawbi, Michael A. Davies, Jeffrey E. Gershenwald, Rodabe N. Amaria, Isabella C. Glitza, Adi Diab, Sapna P. Patel, Jianhua Hu, Jeffrey E. Lee, Elizabeth A. Grimm, Michael T. Tetzlaff, Alexander J. Lazar, Ignacio I. Wistuba, Karen Clise-Dwyer, Brett W. Carter, Jianhua Zhang, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Zachary A. Cooper, Jennifer A. Wargo
Publikováno v:
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-11 (2017)
Melanoma: Tumor differences within a patient may explain heterogeneous responses Patients with metastatic melanoma display molecular and immune differences across tumor sites associated with differential drug responses. A team led by Jennifer Wargo f
Externí odkaz:
https://doaj.org/article/95f4f8da81aa4220b7ea3fea4b7af4b6
Autor:
Patrick Hwu, Michael A. Davies, Laszlo Radvanyi, Jeffrey E. Gershenwald, Jennifer A. Wargo, Thomas F. Gajewski, Jason Roszik, Gregory Lizée, Willem W. Overwijk, Scott E. Woodman, Marcus W. Bosenberg, Roland L. Bassett, Jianhua Hu, Timothy P. Heffernan, Lawrence N. Kwong, Haiyan S. Li, Tina Cascone, Isabella C. Glitza, Jennifer L. McQuade, Rodabe Amaria, Cara Haymaker, Marie-Andree Forget, Chantale Bernatchez, Xiaoxing Yu, Stefani Spranger, Trang N. Tieu, Pei-Ling Chen, Zachary A. Cooper, Carlos A. Torres-Cabala, Alexander J. Lazar, Rina Mbofung, Guo Chen, Wanleng Deng, Leila J. Williams, Xiaoxuan Liang, Chunlei Zhang, Jodi A. McKenzie, Chunyu Xu, Michael T. Tetzlaff, Caitlin Creasy, Shruti Malu, Chengwen Liu, Jie Qing Chen, Weiyi Peng
PTEN loss in melanoma promotes resistance to T cell-mediated anti-tumor activity in the context of concurrent a selective inhibitor for mutant BRAF.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0277424931532ef4ae329209a163cd6e
https://doi.org/10.1158/2159-8290.22531050
https://doi.org/10.1158/2159-8290.22531050
Autor:
Don L. Gibbons, F. Xiao-Feng Qin, John V. Heymach, Ignacio I. Wistuba, Stephen E. Ullrich, Jing Wang, Ethan Dmitrovsky, Vassiliki A. Papadimitrakopoulou, Scott E. Woodman, Lauren Averett Byers, Masanori Kawakami, Jaime Rodriguez-Canales, Jingfen Zhu, Caleb A. Class, Youhong Fan, Carl M. Gay, Brett W. Carter, Weiyi Peng, Ferdinandos Skoulidis, Junna Oba, Pan Tong, Jonathon Roybal, Christin Ungewiss, David H. Peng, Jared J. Fradette, Di Peng, Qiang Zhao, Anfei Huang, Philip L. Lorenzi, Lin Tan, Xi Liu, Tina Cascone, Pamela A. Villalobos, Yanli Li, B. Leticia Rodriguez, Xiaohui Yi, Yongbin Yang, Lixia Diao, Limo Chen
Genes differentially expressed between IgG control and anti-PD-L1 treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c4546034d1bf67810222d236f67110
https://doi.org/10.1158/2159-8290.22532345
https://doi.org/10.1158/2159-8290.22532345
Autor:
Jennifer A. Wargo, Lynda Chin, James P. Allison, Padmanee Sharma, Jorge Blando, P. Andrew Futreal, Jianhua Hu, Arlene H. Sharpe, Willem W. Overwijk, Wencai Ma, R. Eric Davis, Victor Prieto, Lawrence N. Kwong, Rodabe N. Amaria, Ignacio I. Wistuba, Luis M. Vence, Scott E. Woodman, Isabella C. Glitza, Adi Diab, Wen-Jen Hwu, Patrick Hwu, Sapna P. Patel, Alexander J. Lazar, Lauren Haydu, Jeffrey E. Gershenwald, Michael A. Davies, Russell J. Broaddus, Michael T. Tetzlaff, Wei-Shen Chen, Sangeetha M. Reddy, Qing Chang, Hong Jiang, Jacob L. Austin-Breneman, Mariana Petaccia De Macedo, Khalida Wani, Vancheswaran Gopalakrishnan, Roland L. Bassett, John P. Miller, Peter A. Prieto, Christine N. Spencer, Zachary A. Cooper, Alexandre Reuben, Whijae Roh, Pei-Ling Chen
Supplementary Figure 1. Immune profiling of pre-treatment, on-treatment and progression CTLA-4 blockade samples by immunohistochemistry. Supplementary Figure 2. Myeloid cell profiling of pre-treatment, on-treatment and progression CTLA-4 blockade sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a94b76b26635b304089e2c2105c2324
https://doi.org/10.1158/2159-8290.22531185.v1
https://doi.org/10.1158/2159-8290.22531185.v1